Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

June 2024

Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers

2024-06-25T13:59:38+00:00

Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has partnered with Nucleai, a leading spatial AI biomarker company that maps protein expression and cellular interactions within tissue samples to predict therapeutic outcomes. At the center of the collaboration, the companies will integrate Nucleai’s predictive biomarker solutions into Proscia’s Concentriq® software platform and make them available as part of Proscia’s precision medicine AI portfolio to better inform patient care.

Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers2024-06-25T13:59:38+00:00

Cross-Disciplinary Dialogues for Building Out Machine Learning: Advice From the Digital Pathology Road

2024-06-24T10:59:57+00:00

Part seven of our series on the Digital Pathology and AI Congress: USA. Dr Dugger (UC Davis) and Dr Gutman (Emory University) highlighted the importance of cross-disciplinary dialogue and collaboration between pathology and machine learning. Dr. Dugger emphasized clear communication to integrate machine learning into pathology workflows, while Dr. Gutman stressed the need for domain expertise and collaboration to develop effective models. They both underscored continuous dialogue, defined roles, and regular check-ins as essential for building multidisciplinary teams. Extending the dialogue to statisticians, clinical scientists, and others is also crucial. This collaborative approach aims to create clinically relevant AI solutions that enhance patient care.

Cross-Disciplinary Dialogues for Building Out Machine Learning: Advice From the Digital Pathology Road2024-06-24T10:59:57+00:00

Revolutionizing Pathology Practices For Improved Precision Oncology: Leveraging AI to Enhance Efficacy of Immunotherapy

2024-06-20T12:11:10+00:00

Part six of our series on the Digital Pathology and AI Congress: USA discuss Revolutionizing Pathology Practices For Improved Precision Oncology: Leveraging AI to Enhance Efficacy of Immunotherapy

Revolutionizing Pathology Practices For Improved Precision Oncology: Leveraging AI to Enhance Efficacy of Immunotherapy2024-06-20T12:11:10+00:00

Behind The Scenes Of Pathology AI Innovation – Blazej Dolicki’s Insights Into Training, Validation, Deployment, And Beyond

2024-06-19T13:53:14+00:00

Blazej Dolicki, Product Lead of AiosynQC and AI Engineer at Aiosyn, discusses his role in developing AiosynQC by collaborating with pathologists to ensure high-quality standards and adapting to diverse laboratory needs through customizable features. The algorithm is trained on varied image standards from multiple medical centers, validated rigorously for accuracy and efficiency, and designed with robust data security measures. Blazej highlights continuous improvements to AiosynQC based on user feedback and AI advancements to enhance lab productivity and diagnostic accuracy.

Behind The Scenes Of Pathology AI Innovation – Blazej Dolicki’s Insights Into Training, Validation, Deployment, And Beyond2024-06-19T13:53:14+00:00

Roche Receives FDA Clearance On Its Digital Pathology Solution For Diagnostic Use

2024-06-19T11:26:35+00:00

Roche announced today that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the United States Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose patients.

Roche Receives FDA Clearance On Its Digital Pathology Solution For Diagnostic Use2024-06-19T11:26:35+00:00

Opportunities and Obstacles for AI in Pathology

2024-06-14T12:59:50+00:00

Over the past year, many of us have begun interacting with AI tools regularly with little understanding of how they work. We don’t really need to know how ChatGPT responds to our questions or how our photos app tags our family and friends. And if it gets it wrong sometimes, not a big deal – we might even laugh about it.

Opportunities and Obstacles for AI in Pathology2024-06-14T12:59:50+00:00

Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays

2024-06-14T11:19:50+00:00

Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on the BOND RX Fully Automated Research Stainer.

Leica Biosystems and Navinci Partner to Accelerate Cancer Research Through First-Ever Fully Automated In Situ Proximity Ligation Assays2024-06-14T11:19:50+00:00

Reshaping the Future of Medical Care, Education and Research: The Pivotal Roles of Synthetic Data, Generative AI, and Auto-MLs

2024-06-13T08:59:19+00:00

Part five of our series on the Digital Pathology and Ai Congress: USA discuss Reshaping the Future of Medical Care, Education and Research: The Pivotal Roles of Synthetic Data, Generative AI, and Auto-MLs

Reshaping the Future of Medical Care, Education and Research: The Pivotal Roles of Synthetic Data, Generative AI, and Auto-MLs2024-06-13T08:59:19+00:00
Go to Top